Clinical Trials Browser

Interventional × clazakizumab × Clear all

NCT01403064 2021-05-11

Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects

Phase 2 Terminated

76 enrolled 25 charts

Head and Neck Neoplasms, Stomatitis

NCT00866970 2020-07-09

Safety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-related Fatigue and Cachexia

Phase 2 Completed

Cachexia, Fatigue, Lung Neoplasms